Archimedes IndiGO End-Stage Renal Disease Tool Development and Validation
Archimedes IndiGO will be used to predict outcomes for Chronic Kidney Disease and provide an interface for patient management. The accuracy of outcomes prediction will be tested in this study.
Principal Investigator:Stephen F. Derose, MD, MSHS
Funding Source:Kaiser Foundation Health Plan, Inc.
Funding Years:2013 - 2015
Assessing the Relationship between Parental Activation and Obesity-related Health Behaviors among Overweight and Obese Low-income Racial/Ethnic Minority Young Patients
The goal of this study is to determine the association between parental activation and obesity-related health behaviors in overweight/obese youth from low-income or racial/ethnic minority background.
Principal Investigator:Corinna Koebnick, PhD, MSc
Funding Source:Kaiser Permanente and Johns Hopkins Medicine Research Collaboration Committee
Funding Years:2017 - 2018
Cholesterol-lowering medication as risk factors for amyotrophic lateral sclerosis
The primary objective of this study is to investigate whether the use of cholesterol-lowering medications increases the risk of developing ALS or influences the rate of disease progression among individuals who have ALS.
Principal Investigator:Annette M. Langer-Gould, MD, PhD, MS
Funding Source:Centers for Disease Control and Prevention (CDC)
Funding Years:2012 - 2013
Identification of risk factors for resistant Pseudomonas aeruginosa infections with or without ESBL among hospitalized patients and developments and validation of a risk predictive tool
This study aims to develop a clinical risk prediction tool for antibiotic resistant Pseudomonas infections among inpatients.
Principal Investigator:Sara Yee Tartof, PhD, MPH
Funding Source:Merck & Co., Inc.
Funding Years:2016 - 2019
Multiple sclerosis clinical care physician fellowship program
Training and mentoring of resident in treatment of multiple sclerosis.